Skip to content

Clinical trials

Alzheimer Disease trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Argentina Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20072
20085
20095
20103
20121
20132
20143
20151
20163
20172
20182
20201
20215
20223
20232
20245
202513
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated19
Recruiting17
Active, not recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche12
Pfizer8
Bristol-Myers Squibb5
GlaxoSmithKline5
Washington University School of Medicine5
Eli Lilly and Company4
H. Lundbeck A/S3
Merck Sharp & Dohme LLC3
Alector Inc.2
Axovant Sciences Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease64
Dementia17
Cognitive Dysfunction9
Brain Diseases5
Amyloid Neuropathies, Familial4
Amyloidosis4
Central Nervous System Diseases4
Mental Disorders4
Nervous System Diseases4
Polyneuropathies3

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.